MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
48.19
+0.14 (0.29%)
Oct 29, 2024, 4:00 PM EDT - Market closed

MLTX Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
342.79451.1739.518.04
Short-Term Investments
177.0159.8432.61-
Cash & Short-Term Investments
519.8511.0172.118.04
Cash Growth
3.59%608.60%797.08%-
Other Receivables
1.681.060.220.15
Receivables
1.681.060.220.15
Prepaid Expenses
15.412.14.181.45
Total Current Assets
536.88514.1776.519.64
Property, Plant & Equipment
3.873.950.330.05
Other Long-Term Assets
4.138.42--
Total Assets
544.88526.5476.849.68
Accounts Payable
0.180.260.160.03
Accrued Expenses
9.958.147.244.76
Short-Term Debt
---15
Current Portion of Leases
1.321.20.15-
Current Income Taxes Payable
0.620.370.110.06
Other Current Liabilities
0.21--1.23
Total Current Liabilities
12.289.977.6721.09
Long-Term Leases
2.022.50.13-
Total Liabilities
14.8513.058.0821.33
Common Stock
0.010.010.010.04
Additional Paid-In Capital
672609.97129.1942.06
Retained Earnings
-154.6-116.66-80.65-53.64
Treasury Stock
----0.01
Comprehensive Income & Other
3.262.360.35-0.17
Total Common Equity
520.66495.6848.9-11.72
Minority Interest
9.3717.8219.87-
Shareholders' Equity
530.03513.4968.77-11.65
Total Liabilities & Equity
544.88526.5476.849.68
Total Debt
3.343.70.2815
Net Cash (Debt)
516.46507.3171.83-6.96
Net Cash Growth
2.97%606.24%--
Net Cash Per Share
8.6410.332.45-0.89
Filing Date Shares Outstanding
62.8962.8739.150.3
Total Common Shares Outstanding
62.8760.4738.980.3
Working Capital
524.6504.268.85-11.45
Book Value Per Share
8.288.201.25-38.57
Tangible Book Value
520.66495.6848.9-11.72
Tangible Book Value Per Share
8.288.201.25-38.57
Source: S&P Capital IQ. Standard template. Financial Sources.